BIOMAT Database Logo BIOMAT Database Logo

Hypersensitivity reactions during antiretroviral regimens with protease inhibitors. 1997

P Bonfanti, and A Capetti, and P Riva, and L Testa, and T Quirino

UI MeSH Term Description Entries
D006967 Hypersensitivity Altered reactivity to an antigen, which can result in pathologic reactions upon subsequent exposure to that particular antigen. Allergy,Allergic Reaction,Allergic Reactions,Allergies,Hypersensitivities,Reaction, Allergic,Reactions, Allergic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012192 Retroviridae Infections Virus diseases caused by the RETROVIRIDAE. Retrovirus Infections,Infections, Retroviridae,Infections, Retrovirus,XMRV Infection,Xenotropic MuLV-related Virus Infection,Xenotropic Murine Leukemia Virus-related Virus Infection,Infection, Retroviridae,Infection, Retrovirus,Infection, XMRV,Infections, XMRV,Retroviridae Infection,Retrovirus Infection,XMRV Infections,Xenotropic MuLV related Virus Infection,Xenotropic Murine Leukemia Virus related Virus Infection
D017320 HIV Protease Inhibitors Inhibitors of HIV PROTEASE, an enzyme required for production of proteins needed for viral assembly. HIV Protease Inhibitor,Inhibitor, HIV Protease,Inhibitors, HIV Protease,Protease Inhibitor, HIV,Protease Inhibitors, HIV
D019258 Saquinavir An HIV protease inhibitor which acts as an analog of an HIV protease cleavage site. It is a highly specific inhibitor of HIV-1 and HIV-2 proteases, and also inhibits CYTOCHROME P-450 CYP3A. Invirase,Ro 31-8959,Saquinavir Mesylate,Saquinavir Monomethanesulfonate,Saquinivir,Monomethanesulfonate, Saquinavir,Ro 31 8959,Ro 318959
D019438 Ritonavir An HIV protease inhibitor that works by interfering with the reproductive cycle of HIV. It also inhibits CYTOCHROME P-450 CYP3A. ABT 538,ABT-538,Norvir,ABT538
D019469 Indinavir A potent and specific HIV protease inhibitor that appears to have good oral bioavailability. Crixivan,Indinavir Sulfate,Indinavir, Sulfate (1:1),L-735 524,L-735,524,MK-639,L 735 524,L 735,524,L735 524,L735,524,MK 639,MK639,Sulfate, Indinavir

Related Publications

P Bonfanti, and A Capetti, and P Riva, and L Testa, and T Quirino
Higher antiviral activity of antiretroviral regimens including protease inhibitors.
May 1999, AIDS (London, England),
P Bonfanti, and A Capetti, and P Riva, and L Testa, and T Quirino
Different degree of immune recovery using antiretroviral regimens with protease inhibitors or non-nucleosides.
January 2002, AIDS (London, England),
P Bonfanti, and A Capetti, and P Riva, and L Testa, and T Quirino
Prednisolone does not prevent hypersensitivity reactions in antiretroviral drug regimens containing abacavir with or without nevirapine.
December 2001, AIDS (London, England),
P Bonfanti, and A Capetti, and P Riva, and L Testa, and T Quirino
Overcoming obstacles to the success of protease inhibitors in highly active antiretroviral therapy regimens.
December 2002, AIDS patient care and STDs,
P Bonfanti, and A Capetti, and P Riva, and L Testa, and T Quirino
Double-boosted protease inhibitor antiretroviral regimens: what role?
January 2008, Drugs,
P Bonfanti, and A Capetti, and P Riva, and L Testa, and T Quirino
Continued therapy with HIV-1 protease inhibitors, despite previous hypersensitivity reactions, through coadministration of prednisone.
January 1998, Scandinavian journal of infectious diseases,
P Bonfanti, and A Capetti, and P Riva, and L Testa, and T Quirino
Investigational protease inhibitors as antiretroviral therapies.
October 2016, Expert opinion on investigational drugs,
P Bonfanti, and A Capetti, and P Riva, and L Testa, and T Quirino
Immune reconstitution after successful treatment with protease inhibitor-based and protease inhibitor-sparing antiretroviral regimens.
April 2002, Journal of acquired immune deficiency syndromes (1999),
P Bonfanti, and A Capetti, and P Riva, and L Testa, and T Quirino
Hepatotoxicity and antiretroviral therapy with protease inhibitors: A review.
June 2006, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver,
P Bonfanti, and A Capetti, and P Riva, and L Testa, and T Quirino
Abacavir (1592) with protease inhibitors in potent antiretroviral activity.
April 1998, AIDS patient care and STDs,
Copied contents to your clipboard!